Anti-proliferative therapy for HIV cure: a compound interest approach
Abstract In the era of antiretroviral therapy (ART), HIV-1 infection is no longer tantamount to early death. Yet the benefits of treatment are available only to those who can access, afford, and tolerate taking daily pills. True cure is challenged by HIV latency, the ability of chromosomally integra...
Saved in:
Main Authors: | Daniel B. Reeves, Elizabeth R. Duke, Sean M. Hughes, Martin Prlic, Florian Hladik, Joshua T. Schiffer |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/3bd56a0f58ac4f5799ab988ad7daaffa |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
by: Daniel B. Reeves, et al.
Published: (2018) -
Can a topical microbicide prevent rectal HIV transmission?
by: Florian Hladik, et al.
Published: (2008) -
Nonhuman primate models for HIV cure research.
by: Cristian Apetrei, et al.
Published: (2012) -
Editorial: Novel Insights Into a Functional HIV Cure
by: Luca Sardo, et al.
Published: (2021) -
Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement
by: Ani Korhonen, et al.
Published: (2021)